Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6% ...

Pfizer intends to sell about 540 million shares in British consumer healthcare company Haleon, a bookrunner said on Monday, ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of GSK and US rival Pfizer, but was spun out and floated in 2022. US drugs giant Pfizer has sold a stake in Sensodyne ...

Separately, Haleon will also buy around £230 million worth of its shares from Pfizer at the price set in the share offering, ...

Oct 1 (Reuters) - Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and ...

From Tesla's persisting problems to Formula One and LVMH's latest 10-year long tie-up, here's a look at some of the major ...

Haleon, formerly known as DRVW 2022 Ltd, is known for its extensive portfolio in consumer health products, including well-known brands such as Advil, Sensodyne, and Centrum. The company focuses on ...

US drugmaker Pfizer plans to sell about $3.25 billion stake in Haleon, the company behind the toothpaste brand Sensodyne. PepsiCo in reportedly talks to acquire tortilla-chip maker Siete ...